| Factor Information | |
|---|---|
| Data ID | 2780 |
| Factor | CPB time, min |
| Description | CPB time was significantly shorter for the volume overload class than for the other groups. |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | treatment and prognosis |
| Objective | To explore the value of N-terminal-pro-brain natriuretic peptide (NT-ProBNP) as a predictive biomarker of postoperative cardiovascular surgery. |
| p Value | <0.002 |
| Conclusion | CPB time was significantly shorter for the volume overload class than for the other groups. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 623 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
| Reference | |
|---|---|
| PMID | 21131684 |
| Year | 2011 |
| Title | Levels of N-terminal-pro-brain natriuretic peptide in congenital heart disease surgery and its value as a predictive biomarker |
| Sample | ||
|---|---|---|
| Population | infants, children | |
| Source | A prospective study | |
| Region | Madrid, Spain | |
| Method | a prospective observational cohort study | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | Pressure overload(Treatment) | Volume overload(Control) |
| Number | 14 | 37 |
| Age | 0.6 (0.2–180) months | 29 (0.7–182) months |
| Gender (Male: Female) | 27:41 (total) | 27:41 (total) |
| Marker Level | 121.7±53.9 min | 69.4±38.2 min |
